Dr. ZaidAl jebaje, Henry Ford Health System, United States
šBioinformatics:
Dr. Al-Jebaje employs bioinformatics tools in his research to analyze complex data sets, particularly in cardiovascular outcomes and patient management. This analytical approach enhances the precision of his research findings and aids in the development of evidence-based practices.
šCurrent Position:
Dr. Zaid Al-Jebaje is currently engaged in his role at Toledo Cardiology Consultants since July 2024. Prior to this, he completed his fellowship in complex, high-risk, and indicated percutaneous interventions at the Henry Ford Health System in Detroit, Michigan. This fellowship emphasized intricate coronary and peripheral interventions, chronic total occlusions, and mechanical support, reflecting his advanced skill set in interventional cardiology. His education and clinical training have equipped him with a robust foundation for delivering high-quality cardiovascular care.
šAcademic Background:
Dr. Al-Jebaje earned his MBChB from the University of Baghdad College of Medicine in Iraq (2006-2012). He completed his Internal Medicine Residency at the University at Buffalo – Catholic Health System (2016-2019) and subsequently pursued a Cardiovascular Fellowship at the University of Rochester – Strong Memorial Hospital. He further specialized with an Interventional Cardiology Fellowship at the Henry Ford Health System (2019-2023). His extensive education has provided him with the theoretical knowledge and practical skills necessary to excel in his field
šPublication Achievements:
Dr. Al-Jebaje has an impressive publication record, contributing to over 16 peer-reviewed articles in prominent medical journals. His research covers a diverse array of topics in cardiology, including innovative techniques in transcatheter aortic valve replacement (TAVR) and the management of cardiac conditions. Some notable publications include:
- Outcomes following TAVR in patients with cardiogenic shock (2024) – A systematic review and meta-analysis that highlights significant findings in cardiac intervention.
- Retrospective Multicenter Analysis of Intravascular Lithotripsy during imaging-guided interventions, published in the Journal of Society of Cardiovascular Angiography and Intervention (2023).
- Liberal versus Conservative Transfusion Strategy for Patients with Acute Myocardial Infarction and Anemia (2023) – This systematic review and meta-analysis provides insights into transfusion practices.
Dr. Al-Jebaje’s dedication to research is further illustrated by his involvement in ongoing clinical trials and investigations, continually striving to advance the field of cardiology.
š¬Ongoing Research and Research Interests:
Dr. Al-Jebaje’s ongoing research focuses on the efficacy of new interventional techniques and the optimization of patient outcomes in complex cardiac scenarios. His specific interests include:
- Complex Coronary Interventions: Investigating the best practices for treating patients with chronic total occlusions.
- Transcatheter Therapies: Exploring advancements in minimally invasive procedures to improve cardiac health.
- Cardiogenic Shock Management: Evaluating innovative strategies in treating patients experiencing severe heart failure.
These areas reflect his commitment to enhancing the understanding and treatment of cardiovascular diseases, aiming for improved patient care and outcomes.
š¤Professional Associations:
He is an active member of several professional organizations in the field of cardiology, which provide him with platforms for collaboration, continuing education, and sharing advancements in cardiac care. These associations include:
- American College of Cardiology (ACC)
- Society for Cardiovascular Angiography and Interventions (SCAI)
These memberships enable him to stay updated on the latest clinical guidelines and innovations in cardiovascular medicine.
šAwards and ScholarshipsĀ
Throughout his educational journey, Dr. Al-Jebaje has been recognized for his academic excellence and research contributions. While specific awards were not listed, his multiple certifications from the American Board of Interventional Cardiology and other specialties underscore his commitment to lifelong learning and professional development.
š¤Oral Presentations:
He has also delivered several oral presentations at notable conferences, including the SCAISHOCK Conference in Minneapolis (October 2022), where he presented his work on TransCaval LAVA ECMO in cardiogenic shock. Such presentations highlight his role as a thought leader in cardiology, sharing insights and findings with peers in the medical community.
šTraining & WorkshopsĀ
Dr. Al-Jebaje frequently participates in workshops and training sessions to refine his skills and keep abreast of the latest techniques in interventional cardiology. This commitment to ongoing education is essential in a rapidly evolving field like cardiology.
š§ŖLaboratory Experience and Success Factors:
His extensive publications reflect not only his research proficiency but also his laboratory experience, where he has developed a deep understanding of cardiac physiology and intervention techniques. He is committed to translating his findings into clinical practice, aiming for better outcomes in patient care.
Dr. Al-Jebaje attributes his success to a combination of factors:
- Dedication to Patient Care: Always prioritizing the well-being of his patients.
- Continuous Learning: Actively engaging in professional development to enhance his skills.
- Collaboration: Working alongside leading professionals in cardiology to foster innovation.
š ļøTasks Completed as a Researcher:
As a researcher, Dr. Al-Jebaje has successfully managed various projects, from clinical trials to meta-analyses, contributing to the advancement of cardiovascular knowledge. His ability to work collaboratively within multidisciplinary teams has led to significant findings that influence clinical practice.
šConclusion:
In summary, Dr. Zaid Al-Jebaje stands out as a dedicated interventional cardiologist with a wealth of knowledge and experience in complex cardiovascular interventions. His ongoing research, extensive publication record, and commitment to professional development underscore his influence in the field of cardiology. With a focus on improving patient outcomes and advancing cardiac care, he continues to be a vital contributor to medical science and the healthcare community.
- Article Title: Galectin-3 Predicts Long-Term Risk of Cerebral Disability and Mortality in Out-of-Hospital Cardiac Arrest Survivors
Authors: Abdelradi, A., Mosleh, W., Kattel, S., Pokharel, S., Sharma, U.C.
Journal: Journal of Personalized Medicine
Year: 2024
Volume: 14
Issue: 9
Article Number: 994
Citations: 0 - Article Title: Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions
Authors: Riley, R.F., Miller, L.E., Davies, R., Dakroub, A., Ali, Z.A.
Journal: Journal of the Society for Cardiovascular Angiography and Interventions
Year: 2024
Volume: 3
Issue: 2
Article Number: 101213
Citations: 1 - Article Title: Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysis
Authors: Jabri, A., Ayyad, M., Albandak, M., AlQarqaz, M., Villablanca, P.
Journal: Cardiovascular Revascularization Medicine
Year: 2024
Citations: 0 - Article Title: Galectin-3 as a risk predictor of mortality in survivors of out-of-hospital cardiac arrest
Authors: Mosleh, W., Kattel, S., Bhatt, H., Chaudhari, M.R., Sharma, U.C.
Journal: Circulation: Arrhythmia and Electrophysiology
Year: 2019
Volume: 12
Issue: 10
Article Number: e007519
Citations: 6 - Article Title: Spinal tophaceous gout presenting in a young adult without pain
Authors: Al-Jebaje, Z., Elibol, J.M., Peters, J., Alameri, A.
Journal: BMJ Case Reports
Year: 2018
Article Number: 224406
Citations: 5